Trials / Completed
CompletedNCT06156748
CT Imaging for Guiding PA-TACE for HCC
CT Imaging for Guiding Postoperative Adjuvant Transarterial Chemoembolization for Hepatocellular Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,770 (actual)
- Sponsor
- Zhujiang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative adjuvant transarterial chemoembolization (PA-TACE) may improve survival outcomes in a subset of patients with resected hepatocellular carcinoma (HCC), reliable biomarkers for the criterion for the selection of candidates are lacking. The present study aimed to evaluate whether CT imaging can provide more value for predicting benefit from PA-TACE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | postoperative adjuvant transarterial chemoembolization | HCC patients received hepatectomy and PA-TACE. |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2023-12-05
- Last updated
- 2025-07-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06156748. Inclusion in this directory is not an endorsement.